Use of Biomarkers to Guide Decisions on Adjuvant Systemic Therapy for Women With Early-Stage Invasive Breast Cancer: American Society of Clinical Oncology Clinical Practice Guideline Summary

J Oncol Pract. 2016 Apr;12(4):384-9. doi: 10.1200/JOP.2016.010868. Epub 2016 Mar 8.
No abstract available

Publication types

  • Practice Guideline

MeSH terms

  • Biomarkers
  • Breast Neoplasms / diagnosis*
  • Breast Neoplasms / therapy*
  • Clinical Decision-Making
  • Combined Modality Therapy
  • Female
  • Humans
  • Neoplasm Invasiveness
  • Neoplasm Staging

Substances

  • Biomarkers